Oasmia Pharmaceutical AB Buy Hold or Sell Recommendation
| OASMYDelisted Stock | USD 0.06 0.00 0.00% |
Assuming the 90 days horizon and your typical level of risk aversion, our recommendation regarding Oasmia Pharmaceutical AB is 'Not Rated'. Macroaxis provides Oasmia Pharmaceutical buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding OASMY positions. The advice algorithm takes into account all of Oasmia Pharmaceutical's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Oasmia Pharmaceutical's buy or sell advice are summarized below:
Real Value 0.057 | Hype Value 0.06 | Market Value 0.06 | Naive Value 0.052 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Oasmia Pharmaceutical AB given historical horizon and risk tolerance towards Oasmia Pharmaceutical. When Macroaxis issues a 'buy' or 'sell' recommendation for Oasmia Pharmaceutical AB, the advice is generated through an automated system that utilizes algorithms and statistical models.
Oasmia |
Execute Oasmia Pharmaceutical Buy or Sell Advice
The Oasmia recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Oasmia Pharmaceutical AB. Macroaxis does not own or have any residual interests in Oasmia Pharmaceutical AB or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Oasmia Pharmaceutical's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Oasmia Pharmaceutical Trading Alerts and Improvement Suggestions
| Oasmia Pharmaceutical is not yet fully synchronised with the market data | |
| Oasmia Pharmaceutical has some characteristics of a very speculative penny stock | |
| Oasmia Pharmaceutical has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 26.19 M. Net Loss for the year was (132.72 M) with loss before overhead, payroll, taxes, and interest of (15.25 M). | |
| Oasmia Pharmaceutical generates negative cash flow from operations |
Oasmia Pharmaceutical Returns Distribution Density
The distribution of Oasmia Pharmaceutical's historical returns is an attempt to chart the uncertainty of Oasmia Pharmaceutical's future price movements. The chart of the probability distribution of Oasmia Pharmaceutical daily returns describes the distribution of returns around its average expected value. We use Oasmia Pharmaceutical AB price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Oasmia Pharmaceutical returns is essential to provide solid investment advice for Oasmia Pharmaceutical.
| Mean Return | 7.50 | Value At Risk | -16.67 | Potential Upside | 0.00 | Standard Deviation | 53.00 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Oasmia Pharmaceutical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Oasmia Pharmaceutical Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Oasmia . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Oasmia Pharmaceutical Buy or Sell Advice
When is the right time to buy or sell Oasmia Pharmaceutical AB? Buying financial instruments such as Oasmia Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Oasmia Pharmaceutical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Money Market Funds Thematic Idea Now
Money Market Funds
Funds or Etfs investing in various types of short-term (less than one year) fixed income instruments of high-quality and liquidity. The Money Market Funds theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Money Market Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Oasmia Pink Sheet
If you are still planning to invest in Oasmia Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oasmia Pharmaceutical's history and understand the potential risks before investing.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |